Final results of the ISCHEMIA trial. Distinguishing mass media coverage from clinical interpretation

As editors of a niche international cardiovascular journal such as Minerva Cardioangiologica, we are offered the privilege of selecting and supporting new information and perspectives, but we also have a key duty and opportunity. Indeed, we must and may be bold and face tough calls such as providing our own informed, yet surely subjective, opinion on key developments in cardiovascular medicine. A timely and most relevant example is the recent presentation of the final results of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) at the 2019 American Heart Association (AHA) Scientific Sessions held in Philadelphia, PA